Thomas Templeman
Officer at Centessa Pharmaceuticals plc (CNTA)
Thomas Templeman has filed 10 insider reports with the SEC since February 2021, as officer at Centessa Pharmaceuticals plc (CNTA) and officer at Nuvation Bio Inc. (NUVB). Thomas Templeman made no open-market purchases or sales in the last 12 months. The latest filing, on April 4, 2023, reports shares withheld for taxes or exercise price at Centessa Pharmaceuticals plc (CNTA).
- Filings
- 10
- Companies
- 2
- Bought on market
- None
- Sold on market
- $17.8K
Companies where Thomas Templeman is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | 188,244 | $17.8K | Apr 4, 2023 | ||||
| Officersince February 2021 | $3.80 | Feb 12, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 31, 2023CNTASEC Form 4 filed by Templeman ThomasForm 4Shares withheld for taxes or exercise price
- Feb 1, 2023CNTASEC Form 4: Templeman Thomas was granted 60,400 units of Ordinary Shares, increasing direct ownership by 46% to 192,347 unitsForm 4Grant or award
- Sep 30, 2022CNTASEC Form 4: Templeman Thomas covered exercise/tax liability with 5,382 units of Ordinary Shares, decreasing direct ownership by 4% to 134,868 units (for tax liability)Form 4Shares withheld for taxes or exercise price
- Dec 31, 2022CNTASEC Form 4: Templeman Thomas covered exercise/tax liability with 2,921 units of Ordinary Shares, decreasing direct ownership by 2% to 137,329 units to satisfy tax liabilityForm 4Shares withheld for taxes or exercise price
- Nov 23, 2022CNTASEC Form 4 filed by Templeman Thomas (Amendment)Form 4
- Oct 3, 2022-$17.8KCNTASEC Form 4: Templeman Thomas sold $17,844 worth of Ordinary Shares (4,458 units at $4.00), decreasing direct ownership by 3% to 135,792 units (tax liability)Form 4Open-market sale
- Jul 1, 2022CNTASEC Form 4: Templeman Thomas was granted 140,000 units of Ordinary Shares, increasing direct ownership by 56,000% to 140,250 unitsForm 4Grant or award
- Feb 1, 2022CNTASEC Form 4 filed by Templeman ThomasForm 4Grant or award
- Feb 10, 2021NUVBSEC Form 4 filed by Thomas TemplemanForm 4Grant or award
- Feb 10, 2021NUVBSEC Form 3: Thomas Templeman claimed no ownership of No securities owned.Form 3New insider
Compare Thomas Templeman with
- Thomas Templeman vs Gary Hattersley1 shared
- Thomas Templeman vs Philippe Sauvage1 shared
- Thomas Templeman vs Stacy Markel1 shared
- Thomas Templeman vs Kerry Wentworth1 shared
- Thomas Templeman vs Tia L Bush1 shared
- Thomas Templeman vs Iqbal J Hussain1 shared
Other insiders at the same companies
- Gary HattersleyNUVB
- Philippe SauvageNUVB
- Stacy MarkelNUVB
- Kerry WentworthNUVB
- Medicxi Ventures Management (Jersey) LtdCNTA
- Index Ventures Life Vi (jersey) L.P.CNTA
- Tia L BushCNTA
- Iqbal J HussainCNTA
- John J CrowleyCNTA
- Karen M. AndersonCNTA
- Raphael DeferiereCNTA
- Arjun GoyalCNTA
- Francesco De RubertisCNTA
- Stephen KanesCNTA
- Mario Alberto AccardiCNTA
- Mary Lynne HedleyCNTA
Questions about Thomas Templeman
- What is Thomas Templeman's role at Centessa Pharmaceuticals plc?
- Thomas Templeman reports to the SEC as officer at Centessa Pharmaceuticals plc (CNTA), according to the latest filing on April 4, 2023. Thomas Templeman has also filed as officer at Nuvation Bio Inc. (NUVB).
- How many shares does Thomas Templeman own?
- After the latest filing that states it, Thomas Templeman directly owned 188,244 shares of Centessa Pharmaceuticals plc (CNTA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Thomas Templeman bought or sold stock recently?
- The most recent open-market sale was on October 3, 2022: sold 4,458 shares of Centessa Pharmaceuticals plc (CNTA) for $17.8K at an average of $4.00.
- How do I get alerts when Thomas Templeman files?
- Follow Thomas Templeman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Thomas Templeman (SEC CIK 0001654274). Totals count each trade once, skipping amendments whose original is on file, from Feb 12, 2021 on. View on SEC EDGAR · Get this as JSON